Health
Scientists use new technique to study the effects of reactive electrophilic drugs – News-Medical.net
In 2014, the European Medicines Agency approved the drug Tecfidera for the treatment of relapsing multiple sclerosis, a neurodegenerative…
In 2014, the European Medicines Agency approved the drug Tecfidera for the treatment of relapsing multiple sclerosis, a neurodegenerative disease that affects millions of people worldwide. In multiple sclerosis, inflammation damages the protective myelin…
Continue Reading
-
Noosa News21 hours agoPossible severe storms predicted for Queensland’s south-east and Darling Downs
-
General13 hours agoLanlan Yang pleads not guilty over Rolls-Royce crash in Sydney
-
Noosa News20 hours agoMatildas star Kyra Cooney-Cross nominated for ‘Marta’ award for goal of the season
-
Noosa News18 hours agoWin Tickets to Spilt Milk 2025